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ABSTRACT
We have developed an activator/repressor expression
system for budding yeast in which tetracyclines control
in opposite ways the ability of tetR-based activator and
repressor molecules to bind tetO promoters. This
combination allows tight expression of tetO-driven
genes, both in a direct (tetracycline-repressible) and
reverse (tetracycline-inducible) dual system. Ssn6 and
Tup1, that are components of a general repressor
complex in yeast, have been tested for their repressing
properties in the dual system, using lacZ and CLN2 as
reporter genes. Ssn6 gives better results and allows
complete switching-off of the regulated genes, although
increasing the levels of the Tup1-based repressor by
expressing it from a stronger promoter improves
repressing efficiency of the latter. Effector-mediated
shifts between expression and non-expression
conditions are rapid. The dual system here described
may be useful for the functional analysis of essential
genes whose conditional expression can be tightly
controlled by tetracyclines.
INTRODUCTION
Complete sequencing of the Saccharomyces cerevisiae genome
has revealed the existence of a large number of genes without
known function that had evaded previous strategies of study
based on the gene function to structure approach (1). About one
fifth of these so called orphan genes may be essential for cell
growth (2). Systematic analysis of the function of yeast genes
requires a number of independent approaches, some of which
involve the development of new genetic tools (3). The use of
vectors allowing conditional expression of genes is one of these
approaches, either for the study of terminal phenotypes in
conditions where the gene is not expressed and for the analysis of
the effect of gene overexpression on cell physiology.
Recently, we have constructed a set of Tet vectors for
tetracycline-regulated conditional expression of genes in
S.cerevisiae (4), adapted from a previous system developed for
mammalian cells (5). The yeast Tet vectors allow modulation of
the expression levels of genes cloned under the control of the
bacterial Tn10 transposon-derived tetracycline-responsive tetO
promoter, through the action of a tetR-VP16 (tTA) hybrid
transactivator. The tetR moiety of tTA (from Tn10 as well) is
responsible of tetO recognition, while VP16 (from herpes
simplex virus) is the activator moiety. With this direct Tet system,
tetO-driven expression occurs in the absence of the effector
[tetracycline or other molecules of the same antibiotic family,
(4)], while addition of the latter inhibits the tTA activator and
swittches off gene expression. We have shown that different
levels of expression are achieved depending on the number of
tetO boxes in the promoter [two (tetO2) or seven (tetO7) boxes].
Compared to other yeast expression vectors (reviewed in 6), gene
expression from the Tet vectors does not involve changes in
growth medium composition that might cause undesired pleio-
tropic effects on cell metabolism when carrying out gene function
studies. In mammalian cells, a tetracycline-inducible reverse
system has also been developed which allows rapid induction of
tetO-driven gene expression by tetracyclines (7). It is based on a
modified tTA molecule (here named tTA′) containing a mutated
tetR moiety (tetR′) that is activated through binding of the
antibiotic effector molecule.
Given its possible interest as a tool for the systematic functional
analysis of yeast genes, in this work we describe the adaptation of
the mammalian Tet reverse system for yeast cells. In order to achieve
a tighter regulation of expression (that is, a higher ratio of expression
between induced and non-induced conditions), we have also
developed a dual system in which a tetracycline-inactivable tTA
activator and a tetracycline-activable tetR′-Ssn6/Tup1 repressor
co-exist in the same cells. The alternative combination (tTA′
activator plus tetR-Ssn6/Tup1 repressor) has also been developed.
The repressor molecules contain a Ssn6 or Tup1 moiety (actually
the repressor moiety) fused in frame to tetR or tetR′ (acting as the
tetO-binding domain). In S.cerevisiae, complexes of Ssn6 plus
Tup1 act as general co-repressors of a wide number of genes
including cell-type specific, glucose-repressed, oxygen-repressed or
sporulation specific genes (8–11). In these complexes, Tup1
appears to be the active repressor by affecting nucleosome
positioning through its interaction with histones H3 and H4 (12),
although the Tup1 repression function may also involve direct
contact with the RNA polymerase II holoenzyme (13,14). Ssn6
would act as an adaptor between the variable DNA-binding
subunit (that determines promoter specifity) of the repressor
complex and Tup1 (15,16). Although there are discrepancies
from several studies about the size of the Ssn6–Tup1 complexes
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in vitro, there is common agreement that the complexes contain
several Tup1 subunits for each Ssn6 subunit (17,18). By
employing tetR (or tetR′) as DNA-binding domain fused to Ssn6
or Tup1, we demonstrate that the tetracycline-regulated activator/
repressor dual system allows tightly regulatable expression, with
almost undetectable basal levels both when the direct or the
reverse tTA activators are tested.
MATERIALS AND METHODS
Strains, media and growth conditions
Yeast strains employed in this work (Table 1) derive from
S.cerevisiae BMA64-1A (19), which is a derivative from the
commonly employed W303 strain. Cells were grown at 30C in
SD minimal medium plus 2% glucose and the required amino
acids (20). Plasmid transformants were grown in selective
conditions depending on the respective auxotrophic requirements.
For induction of GAL1 promoter-driven gene expression, cells
were pre-grown in SD medium plus 2% raffinose for at least 10
generations, and induction was achieved by addition of 2%
galactose to exponential cells. Induction of tetO promoter-driven
expression by tetracycline or derivatives was carried out as
described in (4). Antibiotic concentration is indicated for each
experiment. Escherichia coli DH5α was employed as bacterial
host for plasmids.
Table 1. Yeast strains
Straina Additional genotype Integrative plasmidb
CML238 CMVp(tetR)::LEU2 pCM218
CML239 CMVp(tetR)::LEU2 pCM148
CML240 CMVp(tetR-SSN6)::LEU2 pCM244
CML241 CMVp(tetR-TUP1)::LEU2 pCM243
CML282 CMVp(tetR-SSN6)::LEU2 pCM242
CML283 CMVp(tetR-TUP1)::LEU2 pCM240
CML288 adh1p(tetR-SSN6)::LEU2 pCM245
CML289 adh1p(tetR-TUP1)::LEU2 pCM246
CML300 adh1p(tetR-SSN6)::LEU2 pCM247
CML301 adh1p(tetR-TUP1)::LEU2 pCM248
aStrains are derived from S.cerevisiae BMA64-1A (MATa ura3-1 ade2-1
leu2-3,112 his3-11,15 trp1-∆2 can1-100) by integration of the corresponding
EcoRV-linearized plasmid at the chromosomal mutated LEU2 locus.
bIntegrative plasmids were constructed as indicated in Materials and Methods.
They contain constructions with the tetO binding moiety-repressor chimeric
protein expressed from the CMV or adh1 promoters. See the text for details on
nomenclature.
Plasmid construction 
Plasmids pCM175 and pCM176 are centromeric vectors (TRP1
as genetic marker for yeast) containing lacZ as reporter gene
under the control of the tetO2 and tetO7 promoters, respectively,
as well as the reverse tTA (tetracycline-inducible) transactivator
gene. To construct them, a 1.7 kb EcoRI–XhoI fragment from
pUGH17-1 (7) with the tetR′ mutated moiety fused in frame to the
VP16 activator was integrated respectively in plasmids pCM161
and pCM159 (4). By substitution of lacZ for the MCS described
in (4), we obtained plasmids pCM251 (tetO2) and pCM252
(tetO7); these are centromeric plasmids with the reverse tTA
system suitable for gene cloning using the restriction sites of the
MCS region.
Plasmid pCM148 (4) is a derivative of the integrative plasmid
YIplac128 (21), with the tetR gene under the control of the
cytomegalovirus promoter (CMVp). Plasmid pCM218 was
constructed from pCM148, and contains the mutated tetR′ moiety
from pUGH17-1 instead of the wild-type one. By linking the
lambda cI spacer (4) to the C-terminal ends of tetR or tetR′ from
pCM148 or pCM218, plasmids pCM217 and pCM223 resulted,
respectively. The latter four plasmids were the basis for additional
plasmid constructions with the Ssn6 or Tup1 repressor moieties
fused in frame to tetR or tetR′. Characteristics of these derivatives
are summarized in Table 1. The SSN6 and TUP1 regions were
isolated from yeast genomic DNA (strain BMA64-1A) by PCR
with the Expand Plus System of Boehringer (using the optimal
conditions specified by the purchaser) and <20 amplification
cycles. For SSN6, the following oligonucleotides were employed:
5′-AGGAAGATCTATGAATCCGGGCGGTGAAC-3′ (a cloning
BglII site and the SSN6 inititiation codon are shown in bold letters)
and 5′-TCCGCTCGAGGTAGATACACAATGAAGGAT-3′ (in
bold letters is a XhoI site used for cloning). The use of the
amplified fragment results in an in-frame fusion from the first
codon of SSN6 to the C-terminus of tetR (or tetR′) through an RS
dipeptide bridge, plus 306 bp downstream of the SSN6 stop
codon. For TUP1, the following oligonucleotides were employed:
5′-GTAAGGGTACCTACGAAGCAGAGATCAAGC-3′ (a KpnI
cloning site and codon number 73 of the TUP1 open reading
frame are in bold letters), and 5′-AGGAATGGCGCCTTGATC-
ATCAAAGAATAATGAACCGCAA-3′ (a NarI site used for
cloning is in bold letters). When the amplified fragment was
cloned in the adequate plasmids (Table 1), this resulted in an
in-frame fusion of tetR (or tetR′) plus the lambda cI spacer
followed by the Tup1 product begining at amino acid 73 of the
original protein. The construction also included 212 bp at 3′ of the
TUP1 stop codon. The Schizosaccharomyces pombe adh1
promoter (adh1p) from pART1 (a gift of Avelino Bueno,
University of Salamanca, Spain) was employed to replace the
CMVp promoter in some plasmids (Table 1). Plasmid pCM250
contains the CLN2 gene with a C-terminal 3× HA epitope under
tetO2 promoter control; it derives from pCM188 (4) by cloning
a PCR-generated blunt-ended fragment containing the tagged
CLN2 gene (to be described elsewhere) in the PmeI site of the
vector. The same PCR-generated fragment was cloned in the
PmeI site of pCM252 to obtain plasmid pCM254 (thus containing
the tagged CLN2 gene under tetO7 promoter control).
Further details on constructions and maps of the plasmids
described here will be given by the authors upon request.
DNA manipulations for plasmid construction and analyses
were performed by standard methods (22). DNA fragments were
isolated from agarose gels using Qiaex columns (Qiagen).
Yeast transformation
Transformation of yeast cells was carried out by the lithium
acetate procedure (23). For integrative transformation of YI-
plac128 derivatives at the chromosomal LEU2 locus, plasmid
DNA previously linearized by digestion at the single EcoRV locus
inside the plasmid LEU2 gene was employed. Integrations were
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checked by Southern analysis using digoxigenin-labeled LEU2
DNA probes.
Northern and western blot analysis
Samples of total RNA for northern analysis were processed (RNA
purification, electrophoresis and blotting to positively-charged nylon
membranes) as described in (22). UV-crosslinked membranes were
washed twice in washing buffer (1% SDS, 20 mM Na2HPO4,
pH 7.2, 1 mM EDTA) at 65C, pre-hybridized for 1 h at 65C in
20% SDS, 0.5% blocking reagent (Boehringer), 250 mM Na2HPO4,
pH 7.2, 1 mM EDTA and hybridized overnight in the same
conditions with a labelled probe (internal to the CLN2 open reading
frame) at 2 ng/ml. Labelling had been performed by random-
priming PCR with digoxigenin-dUTP labelling mixture
(Boehringer). Membranes were washed twice at 65C with washing
buffer, and immunodetection steps were carried out as described by
the manufacturer (Boehringer) using CDP* (Tropix) as chemi-
luminiscent substrate. Signals were detected and quantified with a
Lumi-Imager equipment (Boehringer).
For western blot analysis, protein extracts were prepared from
5 OD600 of exponentially growing cells, by resuspension of cell
pellets in 15 µl of 5 M urea and boiling for 2 min. An equivalent
volume of glass beads was then added and cells were broken by
vortexing (8 min at room temperature), followed by addition of
50 µl of 2% SDS in 0.125 M Tris–HCl buffer, pH 6.8, vortexing for
1 min more, boiling for 2 min and centrifugation. Equivalent
amounts of protein (quantified by the Micro DC protein assay of
BioRad) were separated in SDS–polyacrylamide gels, blotted to
PVDF by electrotransference and immunodetected using a Super
Signal CL HRP-based method (Pierce) and the Lumi-Imager
equipment for signal detection. HA epitope-tagged proteins were
detected with a 1:2500 dilution of the 12CA5 anti-HA monoclonal
antibody. Software of the equipment was employed for
determination of relative signal intensities.
Determination of β-galactosidase activity
β-galactosidase activity (as Miller units) was determined in
toluenized cells as described in (4). Samples were taken from cells
that had been growing exponentially for at least 10 generations in the
conditions (plus or minus antibiotic) specified.
RESULTS AND DISCUSSION
Development of a reverse tTA system for yeast
Gossen et al. (7) have developed a reverse tTA (that is,
tetracycline-inducible) system for mammalian cells, based on a
mutated tetR′ moiety of the transactivator protein that only
recognizes the tetO promoter boxes when interacting with the
antibiotic effector molecules. Adaptation of this system for yeast
cells could provide conditions for overexpressing proteins
without the need to change cells to glucose-minus growth
conditions as occurs with galactose-driven expression. Maintaining
growth conditions as constant as possible may be desirable when
correlations are made between overexpression of a particular
protein and physiological effects. For that purpose, the reverse
system may be advantageous over the direct one since: (i) the
antibiotic should not be required for basal (non-overexpressing)
growth conditions, and (ii) overexpression would not require the
previous dilution of the effector molecules as would occur with
Figure 1. Characterization of the reverse tTA system. As reporter gene, lacZ was
employed under the tetO2 promoter [plasmid pCM171, (4)] or the tetO7 promoter
(plasmid pCM173). (a) Effect of doxycycline concentration on inducibility of the
system. BMA64-1A cells transformed with the corresponding plasmid were grown
exponentially for 20 h in the conditions indicated. Numbers above the bars show
the β-galactosidase activity (Miller units) in the cultures from a representative
experiment. For comparison, enzyme activity in BMA64-1A cells transformed
with pCM154 [containing GAL1-lacZ as reporter gene, (4)] is also shown, after
exponential growth in SD-raffinose medium (–Gal) or after 24 h (in exponential
conditions) of galactose addition to raffinose-grown cells (+Gal). (b) Effect of
several members of the tetracycline antibiotic family on inducibility of the
tetO7-lacZ reporter gene. pCM173-transformed BMA64-1A cells were grown for
24 h in the presence of the antibiotic at 1 µg/ml, before determination of
β-galactosidase activity (Miller units, shown by the numbers).
the direct system, therefore allowing more rapid induction of the
system.
We constructed the centromeric plasmids pCM175 and
pCM176, which contain the reverse tTA transactivator, as well as
the lacZ gene as reporter system under the control of a tetO2
(pCM175) or a tetO7 (pCM176) promoter. Transformants with
any of both plasmids exhibited a marked induction of lacZ
expression by doxycycline (Fig. 1a), with enzyme activity levels
that in the case of the tetO7 promoter are ∼70% of those reached
with a GAL1p-lacZ system. Although no large differences in
maximal expression were observed in the range of doxycycline
concentration between 1 and 5 µg/ml, highest levels were
consistently obtained at 2 µg/ml (Fig. 1a). Concentrations
>5 µg/ml were somewhat toxic for the yeast cells (data not
shown). Doxycycline and tetracycline were the most effective
inducers among the tetracycline family members tested (Fig. 1b),
in accordance with their most effective role in switching-off the
direct tTA system (4) and in correlation with their highest
association equilibrium constant to the Tet repressor of Tn10 (24).
The expression levels achieved in yeast cells with the reverse
tTA system may be adequate for overexpression physiological
studies, and for other types of studies requiring high amounts of
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Figure 2. Tetracycline-regulatable dual (activator/repressor) system for S.cerevisiae. The tetracycline-repressible direct (a) and tetracycline-inducible reverse
(b) systems are depicted. S corresponds in this work to the entire Ssn6 or the truncated (minus the N-terminal 72 amino acids) Tup1 silencer moieties of the repressor
protein. See the text for more details.
protein. However, these advantages may be obscured by the high
basal levels observed, especially in the case of the tetO7 promoter
(Fig. 1a). The incomplete switching-off of the promoter probably
reflects the partial ability of tetR′ to interact with the tetO boxes
in yeast cells even in the absence of effector molecules. This
leakiness, that appears not to occur in mammalian cells (7), has
also been observed by us with other tetO-driven genes such as the
S.cerevisiae CLN2 and CLN3 genes (data not shown, and see
below).
Construction of tetracycline-regulatable dual
(activator/repressor) systems for yeast cells
Taking advantage of the opposite effect of tetracycline molecules
on the ability of the tetR and tetR′ moieties of the respective tTA
activators to interact with the tetO boxes, we have developed two
modalities of a tetracycline-regulatable dual system, that is, a
system in which a tetO-binding activator and a tetO-binding
repressor (both of them regulated by tetracycline in opposite
ways) co-exist in the same cell. The dual system might allow a
tighter regulation of tetO-driven expression, since the presence of
the repressor could lower the basal levels in silencing conditions.
Paralleling the direct and reverse tTA activators, two different types
of tetO-recognizing chimeric repressors have been constructed: the
tetracycline-activable one (co-existing with the direct tTA
activator) consists of tetR′ fused to the silencer moiety, while the
tetracycline-inactivable one (co-existing with the reverse tTA
activator) consists of tetR fused to the silencer moiety. Figure 2
depicts the two modalities of the dual system, that are respectively
switched off and on by the effector antibiotic.
As the silencer moiety of the repressors, we have tested the
entire Ssn6 protein or the truncated Tup1 product lacking the
N-terminal 72 amino acids [that is, the region of Tup1 required for
interaction with Ssn6 (15,16)] of the native protein. In both cases,
the silencer was C-terminal to the tetO-binding moiety. In the
native Ssn6–Tup1 general repressor, Ssn6 acts as a bridge between
the promoter-binding subunit and the Tup1 subunits that actually
perform the silencing role (15,16). Thus, to increase the flexibility
of the final chimeric protein and to separate the DNA-binding
moiety from the silencer one, a lambda cI linker region (4) was
added as spacer between both moieties in the Tup1-based repressors.
Although in the native general repressor Ssn6 and Tup1 are
differentiated subunits from the promoter-recognizing one, previous
studies (8,9,15,16) had shown that Ssn6 and Tup1 have also
repressor activity when fused in frame to promoter-binding regions
forming a single chimeric molecule.
The tetO binding domain-silencer chimeric constructions (initially
under the control of the viral CMVp promoter) were chromosomally
integrated at LEU2, and the resulting strains (Table 1) were
transformed with three tetO7-driven expression plasmids with lacZ
as reporter gene. Plasmids pCM173 (centromeric) and pCM179
(episomal), both of which contain the direct tTA activator (4),
were used to transform strains with the integrated tetR′-silencer
constructions, while pCM176 (centromeric) carrying the reverse
tTA activator was tested on strains with the tetR-silencer
constructions. Measurements of β-galactosidase activity in
induction and non-induction conditions (Table 2) showed that in
the presence of the repressor, basal expression is lowered to
almost undetectable levels when the direct tTA transactivator is
in a centromeric plasmid, both the Ssn6 and Tup1-based
repressors being similarly efficient. Basal levels are also decreased
by the repressors when expression depends on a direct tTA
activator in a multicopy plasmid or in the case of the reverse tTA
activator, although in these situations the Ssn6-based repressor is
more efficient. In fact, basal expession is decreased by the Ssn6
chimeric molecules to levels under detectability in the case of the
reverse system (Table 2). In none case maximal expression is
affected by the presence of the repressor, and growth rate is also
not modified (data not shown).
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Table 2. Expression of a tetO-lacZ reporter construction in different modalities of the activator/repressor dual system
Plasmida tTA activator Repressorb β–galactosidase activity (Miller units  SD) inc
Induction conditions Repression conditions
None – – ≤0.10 ≤0.10
pCM173 Direct CMVp(tetR′) 413.1  50.0 0.45  0.25
(centromeric) CMVp(tetR′–Ssn6) 459.0  68.5 0.16  0.12
CMVp(tetR′–Tup1) 392.8  95.1 0.28  0.18
adh1p(tetR′–Ssn6) 487.2  32.9 0.11  0.09
adh1p(tetR′–Tup1) 501.0  80.1 0.18  0.13
pCM179 Direct CMVp(tetR′) 1013.6  71.7 21.0  9.7
(episomal) CMVp(tetR′–Ssn6) 1014.5  164.1 1.0  0.43
CMVp(tetR–Tup1) 1120.5  101.4 5.6  1.3
pCM176 Reverse CMVp(tetR) 506.0  163.7 127.2  44.7
CMVp(tetR–Ssn6) 556.5  79.8 ≤0.10
CMVp(tetR–Tup1) 378.7  109.8 0.16  0.08
adh1p(tetR–Ssn6) 765.8  183.9 0.11  0.09
adh1p(tetR–Tup1) 557.8  117.9 0.14  0.09
aThe plasmids employed to transform host cells contain the tetO7-lacZ reporter construction.
bThe moieties of the chimeric protein and the promoter under which it is expressed are indicated. Host strains with these constructions
are shown in Table 1.
cMeasurements (from at least three independent experiments) were done in cells grown exponentially during 20 h in induction
or repression conditions; when required, doxycycline was employed at 2 µg/ml. SD, standard deviation.
In the above conditions, repressor expression (as well as that of
tTA) is directed by the cytomegalovirus promoter (4,5). Therefore,
levels of repressor are probably low due to inefficient expression
from the heterologous promoter in yeast cells. We reasoned that
increasing the amount of repressor by expressing it from a
moderately strong promoter in S.cerevisiae cells such as adh1p
from S.pombe, might further reduce expression from tetO in
non-inducing conditions. However, combination of an
adh1p(tetR′-Ssn6) or adh1p(tetR′-Tup1) repressor with a direct
tTA activator in a multicopy plasmid was partially deletereous for
the cells (data not shown). Although no clear explanation exists
for this fact (since it is observed either in induction and
non-induction conditions), other results from us discard the
possibility of repressor interference with replication of 2 µ based
plasmids (not shown). On the other hand, expression of the
chimeric repressors from adh1p did not reduce levels of lacZ
expression in a clear fashion when this gene was in centromeric
plasmids, both with the direct and the reverse systems (Table 2).
Next we analysed regulability of the direct dual system on the
expression of an homologous S.cerevisiae gene such as CLN2,
coding for the G1 cyclin Cln2. For this purpose, we employed a
tetO2–CLN2 construction in a centromeric plasmid (pCM250), in
which CLN2 is C-terminus tagged with three copies of the HA
epitope. Results (Fig. 3) confirmed those previously obtained
with the heterologous lacZ gene. Essentially, the presence of the
tetracycline-activable chimeric repressor (expressed from the
CMV promoter) decreased the basal levels of expression to
almost undetectability when Ssn6 was the silencer constituent of
the repressor moiety. To achieve similar results with Tup1, the
chimeric molecules had to be expressed from the stronger adh1p
promoter. 
The higher performance of Ssn6 when fused to tetR or tetR′
may be explained by its ability to recruite Tup1 subunits,
therefore forming multimeric complexes estructurally similar to
those naturally occurring in the cell. On the contrary, the
excessive proximity of the silencer moiety to the DNA-binding
Figure 3. Regulation of CLN2 expression under tetO2 promoter control using
the dual direct system. Western blots showing the effect of different chimeric
repressor molecules (with the Ssn6 or the Tup1 moieties) expressed from the
CMV or the adh1 promoters in pCM250-transformed cells growing in
non-repression (–Doxy) or repression (+Doxy, 24 h with doxycycline at
2 µg/ml) conditions. The respective host strains are those shown in Table 1. The
Cln2 product was 3× HA-tagged at its C-terminus, and the protein was detected
in the western blots with anti-HA antibodies. Heterogeneous mobility of the
Cln2 molecules is due to differences in phosphorylation levels (26). Signal
levels corresponding to Cln2 were divided by those of a higher-mobility band
(marked with an asterisk) cross-reacting with the 12CA5 antibody that
maintained constant levels of labelling, and then made relative to the signal in
extracts from cells of strain CML204 (as BMA64-1A but containing the
endogenous chromosomal HA-tagged CLN2 gene, left column), which was
given the unit value. Numbers under the photographs represent the values
calculated in this way. nd: non-detectable (relative values 0.005).
moiety may cause some esteric hindrance to the Tup1-based
repressors (lacking Ssn6 as adaptor). This fact may be important
when relatively high basal expression must be lowered. Assuming
that activity of Ssn6 or Tup1-based repressors affects nucleosome
positioning in the sensitive promoter regions (12), our results
support the existence of nucleosomal structure in plasmid
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Figure 4. Kinetics of overexpression of CLN2 using the reverse dual system.
Strains CML238 [CMVp(tetR)] or CML282 [CMVp(tetR-SSN6)] transformed
with pCM254 growing in SD minimal medium were added with doxycycline
(2 µg/ml) at time 0, and samples were taken at the indicated times. As a control,
a sample was also taken from exponentially-growing cultures of strain CML204
(HA-tagged CLN2 expressed from its endogenous promoter). (a) Western blot
analysis of Cln2. Relative levels of Cln2 expressed from the tetO7 promoter (with
respect to those from the endogenous promoter) were calculated as indicated in the
legend of Figure 3, and are shown by the numbers under the respective runs. The
asterisk marks the band that cross-reacts with the 12CA5 antibody. (b) Northern
blot analysis of CLN2 mRNA levels cells growing in the absence or in the presence
of doxycycline (2 µg/ml). Numbers indicate the relative levels of the signal.
promoters (25) and show that this structure is still sensitive to the
general Ssn6–Tup1 repressor.
Kinetics of induction of the reverse dual system
Once shown that the presence of the tetR–Ssn6 repressor
decreased basal levels of the reverse system below detectability
(Table 2), we measured the kinetics of induction of CLN2
expression under tetO7 promoter control in cells containing the
CMVp(tetR–SSN6) construction, which also allowed us to
compare final overexpression steady state levels with those cells
that express CLN2 exclussively from its endogenous promoter.
Previously we had seen (using the tetO7–lacZ reporter system)
that the Tup1-based chimeric repressor caused a slower induction
kinetics than the Ssn6-based one, although final overexpression
β-galactosidase levels did not differ significantly beween both
types of repressor (data not shown). The Cln2 protein began to
accumulate at detectable levels shortly (30 min) after antibiotic
addition, and after 6 h it accumulated ∼13-fold with respect to
steady-state levels in exponentially-growing cells expressing
Cln2 from its own promoter (Fig. 4a).
Cln2 is a rather unstable protein (half-life of ∼10 min) in
exponentially-growing cells expressing normal levels of the
former (26,27). Since the observed half levels of Cln2 after 6 h
in induction conditions could be influenced by changes in the
half-life of the protein in these overexpressing cells, the above
reported numeric values might not reflect the relative strength of
the tetO7 promoter compared with the CLN2 own one. Therefore,
we compared CLN2 mRNA levels between induction and non-
induction conditions in cells that could direct CLN2 transcription
from both promoters (Fig. 4b). In the presence of doxycycline
(both promoters being active), CLN2 mRNA levels are almost
15-fold those of non-induced cells (CLN2 expressed only from its
own promoter). That is, the relative strength of tetO7 when
expressing CLN2 parallels the relative level of the product.
In summary, tetracyclin-regulated expression of tetO-driven genes
in cells that constitutively express a Ssn6- or Tup1-based chimeric
repressor allows tigh control of product levels between induction and
non-induction conditions. When this is applied to the direct system,
it may be useful for the analysis of terminal phenotypes of essential
genes that otherwise could not be studied through this approach, and
also for functional analysis of mutations in non-essential genes
which cause detectable phenotypes. The dual reverse system permits
rapid passage from a tightly-controlled non-expression situation to
high expression conditions without introducing externally-induced
side effects in cell physiology, therefore being an adequate tool for
overexpression phenotypic analyses.
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